← Browse by Condition
Medical Condition

ctla4

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06809530 Phase 1, Phase 2
Recruiting

Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis

Enrollment
34 pts
Location
China
Sponsor
Guangzhou Medical University
View Trial →